Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
GMP Plasmid DNA Manufacturing Market worth $908.50 Million by 2030 - Exclusive Report by InsightAce Analytic | ||
By: PR Newswire Association LLC. - 24 Nov 2022 | Back to overview list |
|
JERSEY CITY, N.J., Nov. 24, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global GMP Plasmid DNA Manufacturing Market By Product(Viral Vectors(Retroviral, Adenoviral, Lentiviral, Adeno-Associated, Others), Plasmid DNA, Non-viral, Lipid/polymer, Electroporation, Nanoparticles, Others), Types (Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics), Application(Gene Therapy, DNA Vaccines, Immunotherapy)) Market Outlook and Industry Analysis 2030". According to company's newest research, the Global GMP Plasmid DNA Manufacturing Market is worth US$ 359.75 Mn in 2021 and is predicted to reach US$ 908.50 Mn in 2030, with a promising CAGR of 11.19% between 2022 and 2030. The major market players includes BioXcellence, Patheon (Thermo Fisher Scientific), Cobra Bio, GenScript ProBio, WuXi Advanced Therapies, Waisman Biomanufacturing, Aldevron, LakePharma, Kaneka Eurogentec S.A., Catalent Biologics, VectorBuilder, VGXI, Inc, Delphi Genetics (Catalent), Esco Aster, Biovian, Vigene Biosciences(Charles River), Cognate BioServices (Charles River), Creative Biolabs, Forge Biologics, Akron Biotech, PackGene Biotech lnc., ACG Biologics, Ajinomoto Bio-Pharma and other market players. Get Sample Report @ https://www.insightaceanalytic.com/request-sample/1437 Plasmid DNA is becoming increasingly crucial in clinical research applications such as gene therapy and genetic vaccination. Good manufacturing procedure (GMP)-grade plasmid DNA is required for direct gene transfer into humans. Plasmids are valuable molecular biology and genetics tools, particularly in genetic engineering. They are essential for cloning genes, making recombinant proteins, and analyzing gene therapy. These plasmid DNA productions scale from a few milligrams to Kilograms. Plasmid DNA is manufactured in different types, in which GMP grade is versatile and has more applications. GMP-grade plasmid DNAs are commonly used for pre-clinical studies, including toxicology and biodistribution studies. This type of plasmid DNA is needed for direct gene transfer into patients. Plasmids are superior to recombinant viruses for manufacturing vaccinations and gene therapies since they can transport massive amounts of DNA without triggering inflammation or cancer. Thus, It is expected that these factors are likely to fuel the market growth. The market growth also contributed to growing awareness of cell and gene therapy. The main factors are the availability of licenced gene therapy products and the rise of cell and gene therapy products used to treat different diseases worldwide. Furthermore, the COVID-19 pandemic led to a share of research into making vaccines to prevent infection. The key market players are performing strategic acquisitions and partnerships, which are responsible for the overall market growth. In March 2021, Charles River acquired the Cognate BioServices for the gene therapy program. Moreover, new companies are starting with cutting-edge technology to meet the growing demand and improve their positions in the global market. However, The progress of the global GMP plasmid DNA manufacturing market is likely to be slowed by the high cost of gene treatments and the risk of insertional mutagenesis. North America dominated the market in 2021, accounting for the largest share. A large number of organizations and institutes engaged in advanced therapy research and development, along with increased demand for effective disease treatment treatments, contribute to regional growth. To address rising demand and expand their position in the global market, prominent companies in North America are approaching the market with cutting-edge technology. The Asia-Pacific region is anticipated to hold the largest market share during the forecast period. The growth is attributed to increased spending on the healthcare sector, and international companies are boosting their spending to promote GMP plasmid DNA production. Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1437 Key Market Developments
For More Information @ https://www.insightaceanalytic.com/customisation/1437 Market Segmentation Global GMP Plasmid DNA Manufacturing Market, by Products, 2022-2030 (Value US$ Mn)
Global GMP Plasmid DNA Manufacturing Market, by Types, 2022-2030 (Value US$ Mn)
Global GMP Plasmid DNA Manufacturing Market, by Application, 2022-2030 (Value US$ Mn)
Global GMP Plasmid DNA Manufacturing Market, by Region, 2022-2030 (Value US$ Mn)
North America GMP Plasmid DNA Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
Europe GMP Plasmid DNA Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
Asia Pacific GMP Plasmid DNA Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
Latin America GMP Plasmid DNA Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
Middle East & Africa GMP Plasmid DNA Manufacturing Market, by Country, 2022-2030 (Value US$ Mn)
Other Related Reports Published by InsightAce Analytic: Global mRNA Synthesis and Manufacturing Services Market Global Lipid Nanoparticles (LNPs) CDMO Market Global DNases, ligases, and RNA Polymerases Market Global Advanced Therapy Medicinal Products CDMO Market Global DNA and Gene Cloning Services Market Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market About Us: InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner. Contact Us: InsightAce Analytic Pvt. Ltd. Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/gmp-plasmid-dna-manufacturing-market-worth-908-50-million-by-2030---exclusive-report-by-insightace-analytic-301686762.html |
||
|
||
Copyright 2022 PR Newswire Association LLC. | Back to overview list |